Kestra Advisory Services’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,039
Closed -$53.3K 2469
2023
Q4
$53.3K Sell
1,039
-618
-37% -$30.3K ﹤0.01% 2215
2023
Q3
$95.8K Sell
1,657
-303
-15% -$15.6K ﹤0.01% 2021
2023
Q2
$87K Hold
1,960
﹤0.01% 2009
2023
Q1
$99K Buy
1,960
+64
+3% +$3.78K ﹤0.01% 1954
2022
Q4
$116K Buy
+1,896
New +$146K ﹤0.01% 2124
2022
Q1
Sell
-4,358
Closed -$739K 2026
2021
Q4
$739K Buy
4,358
+27
+0.6% +$5.42K 0.01% 1110
2021
Q3
$1M Buy
4,331
+310
+8% +$81K 0.01% 1012
2021
Q2
$1.24M Buy
4,021
+2,484
+162% +$776K 0.01% 832
2021
Q1
$536K Buy
+1,537
New +$519K 0.01% 1160

Other funds holding CNBS

Kestra Advisory Services's CNBS Position: Q1 2024 in Review

Kestra Advisory Services sold out of Amplify Seymour Cannabis ETF (CNBS) in Q1 2024, closing a stake of 1,039 shares — an estimated $53.3K sold.

Kestra Advisory Services first reported a position in CNBS in Q1 2021 and held it in 9 quarters. The position peaked at $1.24M in Q2 2021. 27 funds tracked by Wall St. Rank hold CNBS as of Q1 2024.

  • Kestra Advisory Services reported no remaining Amplify Seymour Cannabis ETF position as of Q1 2024 after selling out during the quarter.
  • Kestra Advisory Services sold 1,039 Amplify Seymour Cannabis ETF shares in Q1 2024, an estimated $53.3K.
  • Kestra Advisory Services first reported a position in Amplify Seymour Cannabis ETF in Q1 2021 and held it in 9 quarters.
  • Kestra Advisory Services's Amplify Seymour Cannabis ETF position peaked at $1.24M in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q1 2024.

Based on Kestra Advisory Services's 13F filing for Q1 2024, filed 15 May 2024.